Cardiac resynchronization therapy is associated with:
- Improved quality of life
- Increased exercise capacity
- Reduction in hospitalization for heart failure- Reduction in mortality rates
- Cardiac resynchronization therapy has gained widespread acceptance as a safe, effective therapy for qualifying patients with advanced heart failure.
Massachusetts General Hospital MGH, part of Partners Healthcare provides premier cardiac treatment and research. Treatment for hypertension is a highly specialized, effective medical service at MGH. MGH hypertension treatment emphasizes a multidisciplinary approach to blood pressure control Likewise, cardiac resynchronization therapy, sometimes with defibrillator therapy is an innovative therapeutic option at MGH. Patients with heart failure who experience an abnormality in the pumping of the heartís ventricles can be helped with special treatment to synchronize the pumping. Cardiac resynchronization therapy involves the placement of an implantable biventricular pacing device with three leads (right atrial, right ventricular and left ventricular) that synchronize ventricular contractions. This greatly improves the pumping efficiency of the heart. Clinical care of patients with cardiomyopathy and heart failure and management of patients who have or need a heart transplantation is way above the norm, very superior at MGH.
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education. Mayo Clinic in Rochester, MN is ranked nationally in 15 adult and 10 pediatric specialties. It is a high-performing, high quality care delivery organization, probably the best care delivery in the world, certainly among the top three. Mayo Clinic surgeons perform more than 4,000 cardiac surgeries each year, including numerous complex surgical procedures. The public perception of Mayo universally is that of a very prestigious organization. The research organization is tremendous.